These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6292115)

  • 1. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
    Stoerker J; Yajima Y; Glaser R
    Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
    Glaser R; Tarr KL; Dangel AW
    Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV.
    Fresen KO; Cho MS; Gissmann L; zur Hausen H
    Intervirology; 1980; 12(6):303-10. PubMed ID: 6244234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus with heterogeneous DNA disrupts latency.
    Miller G; Rabson M; Heston L
    J Virol; 1984 Apr; 50(1):174-82. PubMed ID: 6321789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
    Lin JC; Smith MC; Pagano JS
    Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
    Okano M; Aya T; Mizuno F; Takada K; Osato T
    Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV.
    Klein G; Sugden B; Leibold W; Menezes J
    Intervirology; 1974; 3(4):232-44. PubMed ID: 4376804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients.
    Bornkamm GW; von Knebel-Doeberitz M; Lenoir GM
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4930-4. PubMed ID: 6087353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.
    Cho MS; Fresen KO; zur Hausen H
    Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitability of Epstein-Barr virus DNA obtained from superinfected Raji cells for complementary RNA hybridization studies.
    Tanaka A
    J Gen Virol; 1977 Feb; 34(2):375-9. PubMed ID: 190349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines.
    Lewin N; Minarovits J; Weber G; Ehlin-Henriksson B; Wen T; Mellstedt H; Klein G; Klein E
    Int J Cancer; 1991 Apr; 48(1):62-6. PubMed ID: 1850384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.
    Shaw JE; Levinger LF; Carter CW
    J Virol; 1979 Feb; 29(2):657-65. PubMed ID: 219253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains.
    Desgranges C; Lavoué MF; Patet J; de-Thé G
    Biomedicine; 1979 Jun; 30(2):102-8. PubMed ID: 224964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.